SUPREME TEAM

23andMe to slash 40% of its workforce, end therapeutics program to cut costs

23andMe to slash 40% of its workforce, end therapeutics program to cut costs

DNA-testing company 23andMe Holding Co. will slash its workforce by about 40% and discontinue its therapeutics program as part of a restructuring effort to cut costs, the company said Monday…
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

NEWS & INSPIRATION

More Article.

Follow & Subscribe to our Newsletter.

Ready to get started, Get our Newsletter and join the Community!